$10.85
0.03 (-0.28%)
Last updated: Apr 16, 2026 02:39
Fundamentals Overview
Medifast, Inc. is in the middle of its 52-week range with low valuation, trading relatively flat today.
Valuation low
Intrinsic value (DCF)
+509.1% upside vs price
Risk (Beta)
0.56 — lower vol
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +509.1% upside vs price · Analyst grade: B-
Pressures (Sell):
Sentiment weakening (5 downgrades) · 3M vs S&P 500: -7.9%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B-. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 11, Equal Weight: 1, Hold: 2, Neutral: 14, Underperform: 2.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $66.09; current price is $10.85. That’s a +509.1% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | N/A |
| DCF value (model) | $66.09 (509.1% upside) |
| PEG (TTM) | N/A |
| P/B (TTM) | 0.6 |
| P/S (TTM) | 0.31 |
| P/FCF (TTM) | 95.48 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 4.69 |
| Quick Ratio (TTM) | 4.22 |
| Cash Ratio (TTM) | 2.08 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | -4.84% |
| Gross margin (TTM) | 71.33% |
| Operating margin (TTM) | -3.68% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for MED.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Stephens & Co. | maintain | Equal Weight | Equal Weight | 2026-02-19 |
| DA Davidson | maintain | Neutral | Neutral | 2025-02-19 |
| DA Davidson | upgrade | Underperform | Neutral | 2024-11-05 |
| DA Davidson | maintain | Underperform | Underperform | 2024-07-22 |
| DA Davidson | downgrade | Neutral | Underperform | 2024-06-05 |
| DA Davidson | maintain | Neutral | Neutral | 2024-04-30 |
| DA Davidson | maintain | Neutral | Neutral | 2024-02-21 |
| DA Davidson | maintain | Neutral | Neutral | 2023-08-08 |
| DA Davidson | maintain | Neutral | Neutral | 2023-08-07 |
| DA Davidson | maintain | Neutral | Neutral | 2023-07-31 |
| DA Davidson | maintain | Neutral | Neutral | 2023-07-30 |
| DA Davidson | maintain | Neutral | Neutral | 2023-05-02 |
| DA Davidson | maintain | Neutral | Neutral | 2023-05-01 |
| DA Davidson | maintain | Neutral | Neutral | 2023-02-22 |
| DA Davidson | maintain | Neutral | Neutral | 2023-02-21 |
| DA Davidson | downgrade | Buy | Neutral | 2022-11-04 |
| DA Davidson | downgrade | Buy | Neutral | 2022-11-03 |
| DA Davidson | maintain | Buy | Buy | 2022-08-04 |
| Jefferies | downgrade | Buy | Hold | 2022-08-04 |
| Jefferies | downgrade | Buy | Hold | 2022-08-03 |
| DA Davidson | maintain | Buy | Buy | 2022-08-03 |
| DA Davidson | maintain | Buy | Buy | 2022-06-02 |
| DA Davidson | maintain | Buy | Buy | 2022-06-01 |
| DA Davidson | maintain | Buy | Buy | 2022-02-24 |
| DA Davidson | maintain | Buy | Buy | 2022-02-23 |
| DA Davidson | maintain | Buy | Buy | 2021-11-08 |
| DA Davidson | maintain | Buy | Buy | 2021-11-07 |
| DA Davidson | maintain | Buy | Buy | 2021-05-05 |
| DA Davidson | maintain | Buy | Buy | 2021-05-04 |
| DA Davidson | maintain | Buy | Buy | 2021-02-26 |